Forte Biosciences, Inc. Quarterly Current Ratio in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Forte Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2017 to Q3 2024.
  • Forte Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 458 %, a 39% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 458 -293 -39% Sep 30, 2024
Q2 2024 605 -381 -38.7% Jun 30, 2024
Q1 2024 711 -789 -52.6% Mar 31, 2024
Q4 2023 719 -1.29K -64.2% Dec 31, 2023
Q3 2023 751 -1.69K -69.2% Sep 30, 2023
Q2 2023 986 -1.05K -51.6% Jun 30, 2023
Q1 2023 1.5K -363 -19.5% Mar 31, 2023
Q4 2022 2.01K +192 +10.6% Dec 31, 2022
Q3 2022 2.44K +552 +29.2% Sep 30, 2022
Q2 2022 2.04K +147 +7.78% Jun 30, 2022
Q1 2022 1.86K +283 +17.9% Mar 31, 2022
Q4 2021 1.81K +1.22K +203% Dec 31, 2021
Q3 2021 1.89K +1.54K +436% Sep 30, 2021
Q2 2021 1.89K +1.71K +929% Jun 30, 2021
Q1 2021 1.58K +1.37K +654% Mar 31, 2021
Q4 2020 599 +312 +108% Dec 31, 2020
Q3 2020 352 +12.2 +3.59% Sep 30, 2020
Q2 2020 184 -338 -64.8% Jun 30, 2020
Q1 2020 210 -360 -63.2% Mar 31, 2020
Q4 2019 287 -269 -48.3% Dec 31, 2019
Q3 2019 340 -198 -36.8% Sep 30, 2019
Q2 2019 522 -21.7 -3.99% Jun 30, 2019
Q1 2019 570 -1.5 -0.26% Mar 31, 2019
Q4 2018 556 +49.2 +9.72% Dec 31, 2018
Q3 2018 537 +100 +22.9% Sep 30, 2018
Q2 2018 544 Jun 30, 2018
Q1 2018 571 Mar 31, 2018
Q4 2017 506 Dec 31, 2017
Q3 2017 437 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.